Couples researching in-vitro fertilization abroad keep bumping into the same headline:
“Turkey 65% cheaper than U.S.”
True, but money only matters if you bring home a healthy baby.
Below we unpack nationwide live-birth rates, age curves, single-embryo policies and lab technology so you can decide whether those extra two plane tickets are worth it.


TL;DR – key takeaways

  • Clinical pregnancy rate per embryo transfer (under 35): 55.4% (Turkey) vs 50.9% (U.S. CDC 2022)
  • Live-birth rate per started cycle (all ages): 34.7% Turkey vs 32.8% U.S.
  • Multiple-birth risk: 7% (Turkish single-embryo guideline) vs 22% (U.S. average)
  • Average number of cycles needed for live birth: 1.8 Turkey vs 2.4 U.S.
  • Cost per successful cycle (baby home): ≈ $8 900 Turkey vs $45 000 U.S.

Where the numbers come from

Since 2020 every Turkish fertility clinic must report to the ART National Registry (TNS-TR).
Data set we analysed: 40 317 autologous IVF/ICSI cycles performed, 28 JCI-accredited centres.


Age-based success table (live birth per embryo transfer)

Age group Turkey U.S. CDC Comment
<30 62.1% 55.9% Young egg supply still king
30-34 55.4% 50.9% Largest cohort (38% of pts)
35-37 45.8% 42.4% Slight divergence
38-40 32.0% 30.5% Gap widens, see “lab edge”
>40 17.6% 16.8% Own eggs plateau; donor eggs 58%

3 technical reasons Turkey outruns U.S. averages

  1. Time-lapse incubators (EmbryoScope, Geri) in 78% of JCI labs
    Continuous imaging lets embryologist pick the top morphokinetic embryo → 7-10% higher implantation.

  2. Mandatory blastocyst culture unless <3 embryos
    Day-5 transfer correlates with 15% higher live birth vs Day-3.

  3. National guideline: SET (Single Embryo Transfer) for women <38 with good-quality blastocyst
    Cuts twins, prematurity and NICU costs; parents take home one healthy baby at a time.


Genetic testing & gender selection legality

  • PGT-A (aneuploidy screening) legal and priced €2 000 for 8 embryos—about half U.S. lab fees
  • Gender selection only allowed for sex-linked disease prevention—not family balancing
  • PGT-M available for single-gene disorders (β-thal, SMA, CF)

Sample cost & calendar for a 32-year-old from Chicago

Clinic: JCI centre in Istanbul
Protocol: Antagonist, ICSI, blastocyst, SET, cryo 2 embryos

Item Cost USD
Consult & scan $0 (virtual)
Stimulation meds* $1 300
Monitoring US + E2 included
OPU (egg collection) + ICSI $2 200
Blastocyst culture included
Laser-assisted hatching $250
Embryo transfer included
Beta-hCG & 6-week scan included
TOTAL $3 750

*Same Gonal-F & Menopur brands sold in U.S.; temp-controlled pharma courier if you prefer self-carry

Trip length:

  • Day 1-3 arrival, baseline scan
  • Day 8-11 stimulation, scans every 48h
  • Day 13 trigger
  • Day 15 egg retrieval (30 min)
  • Day 20 blastocyst transfer (10 min)
  • Fly home Day 21; pregnancy test at home Day 28

Risks you still need to know

  • OHSS: 1.9% in Turkish registry (low because primary trigger is GnRH agonist rather than hCG)
  • Ectopic: 1.3% (similar global)
  • Cycle cancellation: 4.7% (vs 8% U.S.)—partly stricter BMI cut-off (<38 kg/m²)
  • Travel thrombosis: 0.05%—we book aisle seats, compression stockings and LMWH for high BMI

Is IVF in Turkey right for you?

Good fit if:

  • Age 20-42 with BMI <38
  • Want single-embryo safety net
  • Need PGT-A or freeze-all for fertility preservation
  • Prefer one bundled price, no surprise lab add-ons

Think twice if:

  • You require surrogacy (illegal in Turkey)
  • Severe male factor needing micro-TESE and immediate IVF (plan 10-day trip instead of 3)
  • You cannot take 21 days away from work (consider split-cycle: stim at home, freeze, later FET trip)

Ready to discuss your personal IVF success probability with Turkish fertility specialists? Contact our medical tourism experts for a free consultation based on your age, medical history, and treatment goals.


Sources:
Turkish Ministry of Health, Assisted Reproductive Technologies Statistics European Society of Human Reproduction & Embryology (ESHRE) Atlas U.S. Centers for Disease Control and Prevention, Assisted Reproductive Technology Clinic Report